Invest Now
Products Pricing Partners Refer & Earn

Platforms

Trading Options

Platforms

Trading Options

Pricing

Trading & Investing

Calculators

Support

Learn

IPO

About Us

Partners

Refer & Earn

Open an account Login

Bacil Pharma Ltd Share Price (Suspended)

₹ 40.57 0 (0%)

Updated on 05-05-2025 4:00 PM

Stock Rating

Pros 1

 

Cons 8
GRAPH NOT FOUND

Bacil Pharma Ltd Price Performance

  • Day's Low
  • ₹0
  • Day's High
  • ₹0
₹ 40.57
  • 52-w low
  • ₹0
  • 52-w high
  • ₹0
40.57
  • Day's open
    ₹0
  • Previous close
    ₹0
  • VWAP
    ₹0
  • Lower price band
    ₹0
  • Upper price band
    ₹0

Today's Market Action

Its last traded stock price on BSE was 40.57 down by %. The total volume of shares on NSE and BSE combined was 0 shares. Its total combined turnover was Rs 0.00 crores.

Bacil Pharma Ltd Medium and Long Term Market Action

The stock price of Bacil Pharma Ltd is down by 0% over the last one month. Don't forget to check the full stock price history in the table below.

Bacil Pharma Ltd Fundamentals

  • Market Cap (Cr): 23.9

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Bacil Pharma Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Bacil Pharma Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Bacil Pharma Ltd

Data not available.

Bacil Pharma Ltd FAQ's

What is Share Price of Bacil Pharma Ltd?

What is the Market Cap of Bacil Pharma Ltd?

What is PE Ratio of Bacil Pharma Ltd?

What is PB Ratio of Bacil Pharma Ltd?

What is the CAGR of Bacil Pharma Ltd?

How to Buy Bacil Pharma Ltd Share?

Can I buy Bacil Pharma Ltd from Samco?

How do I buy Bacil Pharma Ltd from Samco?

Financials

Samco trading menu icon samco trading icon
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Samco trading Pros iconPros

Samco downarrow
  • Zero Debt
    The company has almost nil to negligible debt to equity ratio of 0.09. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

samco consiconCons

Samco downarrow
  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Poor Cash Flow Conversion
    The business has very poor cash conversion ratio of only 0.00% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
  • Negative operating earnings and interest coverage
    The company has a negative operating earnings and a negative Interest coverage ratio of -Infinity times which implies that the company has no operating earnings to pay for interest which is currently being paid out of capital and/or other income. This is extremely negative for shareholders.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Poor Capital Allocation
    The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 80.65 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of Infinity days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • Poor Corporate Governance
    The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Samco downarrow
Margin of safety
(09/05/2025)
Stock Valuation
Dark green line
118
samco thumsup icon100.00%
100.00% People are bullish about Bacil Pharma Ltd
samco thumdown icon0.00%
0.00 % People are bearish about Bacil Pharma Ltd

What is your opinion about this Stock?

Historical Data

Bacil Pharma Ltd

₹ 40.57 0 (0%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      samco trading app down arrow
      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon
      Open Free Account Now

      Open Free Trading & Demat Account

      +91